Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Conditions
- Gastrinoma
- Glucagonoma
- Insulinoma
- Metastatic Gastrointestinal Carcinoid Tumor
- Metastatic Pheochromocytoma
- Pancreatic Polypeptide Tumor
- Recurrent Gastrointestinal Carcinoid Tumor
- Recurrent Islet Cell Carcinoma
- Recurrent Melanoma
- Recurrent Neuroendocrine Carcinoma of the Skin
- Recurrent Non-small Cell Lung Cancer
- Recurrent Pheochromocytoma
- Recurrent Renal Cell Cancer
- Somatostatinoma
- Stage III Neuroendocrine Carcinoma of the Skin
- Stage IV Melanoma
- Stage IV Non-small Cell Lung Cancer
- Stage IV Renal Cell Cancer
- Thyroid Gland Medullary Carcinoma
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: everolimus
- DRUG: vatalanib
- OTHER: pharmacological study
- OTHER: laboratory biomarker analysis
- PROCEDURE: dynamic contrast-enhanced magnetic resonance imaging
- PROCEDURE: ultrasound imaging
Sponsor
Mayo Clinic